-
1
-
-
67649610037
-
Response variability and the role of platelet function testing
-
P.A. Gurbel, E. Mahla, and M.J. Antonino Response variability and the role of platelet function testing J Invasive Cardiol 21 2009 172 178
-
(2009)
J Invasive Cardiol
, vol.21
, pp. 172-178
-
-
Gurbel, P.A.1
Mahla, E.2
Antonino, M.J.3
-
2
-
-
69249219296
-
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
-
(2009)
JAMA
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
O'Connell, J.R.2
Bliden, K.P.3
-
3
-
-
73149119363
-
Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite
-
M. Kazui, Y. Nishiya, and T. Ishizuka Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite Drug Metab Dispos 38 2010 92 99
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 92-99
-
-
Kazui, M.1
Nishiya, Y.2
Ishizuka, T.3
-
4
-
-
58749094444
-
Cytochrome p-450 polymorphisms and response to clopidogrel
-
J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
-
(2009)
N Engl J Med
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
-
5
-
-
77953911457
-
Consensus and future directions on the definition of high on-treatment platelet reactivity to ADP
-
L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to ADP J Am Coll Cardiol 56 2010 919 933
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 919-933
-
-
Bonello, L.1
Tantry, U.S.2
Marcucci, R.3
-
6
-
-
18044398749
-
12 receptor antagonist activity
-
DOI 10.1055/s-2005-869524
-
Y. Niitsu, J.A. Jakubowski, and A. Sugidachi Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity Semin Thromb Hemost 31 2005 184 194 (Pubitemid 40605193)
-
(2005)
Seminars in Thrombosis and Hemostasis
, vol.31
, Issue.2
, pp. 184-194
-
-
Niitsu, Y.1
Jakubowski, J.A.2
Sugidachi, A.3
Asai, F.4
-
7
-
-
37849002889
-
Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
-
L. Wallentin, C. Varenhorst, and S. James Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease Eur Heart J 29 2008 21 30
-
(2008)
Eur Heart J
, vol.29
, pp. 21-30
-
-
Wallentin, L.1
Varenhorst, C.2
James, S.3
-
8
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
-
9
-
-
73949112820
-
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study
-
P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
-
(2009)
Circulation
, vol.120
, pp. 2577-2585
-
-
Gurbel, P.A.1
Bliden, K.P.2
Butler, K.3
-
10
-
-
77950508416
-
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: The RESPOND study
-
P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199
-
(2010)
Circulation
, vol.121
, pp. 1188-1199
-
-
Gurbel, P.A.1
Bliden, K.P.2
Butler, K.3
-
11
-
-
0038649988
-
Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
-
DOI 10.1161/01.CIR.0000072771.11429.83
-
P.A. Gurbel, K.P. Bliden, and B.L. Hiatt Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
-
(2003)
Circulation
, vol.107
, Issue.23
, pp. 2908-2913
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hiatt, B.L.3
O'Connor, C.M.4
-
12
-
-
56549090507
-
Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: A potential antiplatelet therapeutic target
-
P.A. Gurbel, M.J. Antonino, and K.P. Bliden Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target Platelets 19 2008 595 604
-
(2008)
Platelets
, vol.19
, pp. 595-604
-
-
Gurbel, P.A.1
Antonino, M.J.2
Bliden, K.P.3
-
13
-
-
44949173754
-
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
-
DOI 10.1093/eurheartj/ehn046
-
M.J. Price, S. Endemann, and R.R. Gollapudi Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
-
(2008)
European Heart Journal
, vol.29
, Issue.8
, pp. 992-1000
-
-
Price, M.J.1
Endemann, S.2
Gollapudi, R.R.3
Valencia, R.4
Stinis, C.T.5
Levisay, J.P.6
Ernst, A.7
Sawhney, N.S.8
Schatz, R.A.9
Teirstein, P.S.10
-
14
-
-
41249093357
-
Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance. A Multicenter Randomized Prospective Study
-
DOI 10.1016/j.jacc.2007.12.044, PII S0735109708005664
-
L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 2008 1404 1411 (Pubitemid 351447314)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.14
, pp. 1404-1411
-
-
Bonello, L.1
Camoin-Jau, L.2
Arques, S.3
Boyer, C.4
Panagides, D.5
Wittenberg, O.6
Simeoni, M.-C.7
Barragan, P.8
Dignat-George, F.9
Paganelli, F.10
-
15
-
-
37349111065
-
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial
-
DOI 10.1161/CIRCULATIONAHA.107.740324
-
S.D. Wiviott, D. Trenk, and A.L. Frelinger Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial Circulation 116 2007 2923 2932 (Pubitemid 350291199)
-
(2007)
Circulation
, vol.116
, Issue.25
, pp. 2923-2932
-
-
Wiviott, S.D.1
Trenk, D.2
Frelinger, A.L.3
O'Donoghue, M.4
Neumann, F.-J.5
Michelson, A.D.6
Angiolillo, D.J.7
Hod, H.8
Montalescot, G.9
Miller, D.L.10
Jakubowski, J.A.11
Cairns, R.12
Murphy, S.A.13
McCabe, C.H.14
Antman, E.M.15
Braunwald, E.16
-
16
-
-
77953914877
-
Genotyping one piece of the puzzle to personalize antiplatelet therapy
-
P.A. Gurbel, U.S. Tantry, and A.R. Shuldiner Genotyping one piece of the puzzle to personalize antiplatelet therapy J Am Coll Cardiol 56 2010 112 116
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 112-116
-
-
Gurbel, P.A.1
Tantry, U.S.2
Shuldiner, A.R.3
-
17
-
-
79960173071
-
-
Available at:. Last accessed July 28, 2010
-
Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2010/ 020839s042lbl.pdf. Last accessed July 28, 2010.
-
-
-
-
18
-
-
79952598836
-
GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
-
M.J. Price, P.B. Berger, and P.S. Teirstein GRAVITAS Investigators. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
-
(2011)
JAMA
, vol.305
, pp. 1097-1105
-
-
Price, M.J.1
Berger, P.B.2
Teirstein, P.S.3
-
19
-
-
79960200465
-
-
Available at:. Last accessed July 28, 2010
-
Available at: http://clinicaltrials.gov/ct2/show/NCT00910299?term= TRIGGER-PCI&rank=1. Last accessed July 28, 2010.
-
-
-
-
20
-
-
69549112962
-
New P2Y12 antagonists
-
A.D. Michelson New P2Y12 antagonists Curr Opin Hematol 16 2009 371 377
-
(2009)
Curr Opin Hematol
, vol.16
, pp. 371-377
-
-
Michelson, A.D.1
-
21
-
-
48449101872
-
The association of cigarette smoking with enhanced Platelet inhibition by clopidogrel
-
K.P. Bliden, J. Dichiara, and L. Lawal The association of cigarette smoking with enhanced Platelet inhibition by clopidogrel J Am Coll Cardiol 52 2008 531 533
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 531-533
-
-
Bliden, K.P.1
Dichiara, J.2
Lawal, L.3
-
22
-
-
58349091115
-
Relationship between age and platelet activation in patients with stable and unstable angina
-
J.R. Gilstad, P.A. Gurbel, and R.E. Andersen Relationship between age and platelet activation in patients with stable and unstable angina Arch Gerontol Geriatr 48 2009 155 159
-
(2009)
Arch Gerontol Geriatr
, vol.48
, pp. 155-159
-
-
Gilstad, J.R.1
Gurbel, P.A.2
Andersen, R.E.3
|